The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4
- 22 January 1993
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1180 (3) , 313-320
- https://doi.org/10.1016/0925-4439(93)90056-7
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitationClinical and Experimental Immunology, 1990
- DEFICIENCY OF C4A IS A GENETIC DETERMINANT OF SYSTEMIC LUPUS ERYTHEMATOSUS IN THREE ETHNIC GROUPSInternational Journal of Immunogenetics, 1987
- Complement‐mediated adherence of immune complexes to human erythrocytesFEBS Letters, 1987
- The Role of Complement and Its Receptor in the Elimination of Immune ComplexesNew England Journal of Medicine, 1986
- Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.The Journal of Experimental Medicine, 1984
- Conformational and functional changes in the fourth component of human complement produced by nucleophilic modification and by proteolysis with C1.lovin.sBiochemistry, 1982
- Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes.The Journal of Experimental Medicine, 1981
- Treatment of Human Complement Components C4 and C3 with Amines or Chaotropic IonsScandinavian Journal of Immunology, 1981
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970